Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (2)
  • 2024 (3)
  • 2023 (5)
  • 2022 (2)
  • 2021 (3)
  • 2020 (1)

Subject

  • Drug Trafficking (357)
  • Synthetic drugs (303)
  • Fake Pills (212)
  • Guns/Weapons (95)
  • Seizures (Drugs/Property) (83)
  • OCDETF/Task Force (70)
  • Take Back Day (51)
  • Prescription Drugs (44)
  • Guilty Plea (40)
  • Outreach/Drug Prevention (33)
  • Diversion Division (30)
  • Arrests/Convictions - Major (21)
  • Major Law Enforcement Operation (17)
  • Overdose (17)
  • Public and Media Affairs - also see Congressional Affairs (17)
  • Money Laundering (16)
  • Press Conferences (16)
  • Fentanyl Awareness (15)
  • HIDTA (14)
  • Gangs (13)
  • Congressional Affairs (12)
  • One Pill Can Kill (10)
  • Prevention/Education - DEA websites GSAD, JTT etc (9)
  • Red Ribbon (9)
  • Extraditions (6)
  • Intergovernmental Affairs (4)
  • International/Foreign Operations (4)
  • Narcoterrorism (4)
  • Critical Incident (3)
  • Dark Web- Internet Trafficking (3)
  • Task Forces/Task Force Officers (3)
  • Fentanyl Free America (2)
  • Scam Calls (2)
  • Terrorism (2)
  • Asset Forfeiture (1)
  • Intelligence Division - Intelligence Products (1)
  • Museum and Visitors Center (1)
  • Other (1)
  • Pharmaceuticals/Pharmacists/Physicians (16)

Drug Name

  • Opioids (3)
  • Oxycodone (3)
  • Benzodiazepines (2)
  • Fentanyl (2)
  • Hydromorphone (2)
  • GHB (1)
  • Ketamine (1)
  • Methadone (1)

Field Division

  • Washington, DC (35)
  • St. Louis (32)
  • New York (21)
  • Chicago (19)
  • Miami (16)
  • Atlanta (12)
  • New Jersey (11)
  • El Paso (9)
  • Dallas (8)
  • Houston (7)
  • San Francisco (7)
  • Louisville (5)
  • New England (5)
  • San Diego (5)
  • Los Angeles (4)
  • New Orleans (4)
  • Rocky Mountain (3)
  • Omaha (2)
  • Phoenix (2)
  • Philadelphia (1)
  • Sede (9)
  • Seattle (7)
Clear All Results
PRESS RELEASE

UW Medicine Resident Physician at Seattle Children’s Hospital Charged for Diverting Fentanyl

Julio 01, 2025
SEATTLE, Wash.--Dr. Andrew Voegel-Podadera, 35, a resident physician at the University of Washington Medical School who worked at Seattle Children’s Hospital, UW Medicine, and Harborview Medical Center is charged with two counts of Acquiring a Controlled Substance by Misrepresentation, Fraud, Deception, and Subterfuge. On June 24th, 2025, DEA Seattle Diversion...
Julio 01, 2025
PRESS RELEASE

DEA Safely Disposes of 620,000 Pounds of Unused Medications on 28th National Prescription Drug Take Back Day

Mayo 08, 2025
WASHINGTON – DEA and nearly 4,500 law enforcement agencies joined forces last month to dispose of more than 620,000 pounds of unneeded and expired medications in an effort to prevent drug misuse and abuse. The spring collection event marked DEA’s 28th National Prescription Drug Take Back Day. Since its inception...
Mayo 08, 2025
PRESS RELEASE

Sweeping DEA Operation Targets Pharmacy Burglaries and the Illegal Sale of Addictive Prescription Medications

Agosto 29, 2024
WASHINGTON – The U.S. Drug Enforcement Administration has seen an increase in burglaries at independent pharmacies across the country. Nearly 900 burglaries involving the theft of controlled substances were reported to DEA in 2023. Stolen prescription medications adversely impact these small businesses while also putting patients and the community at...
Agosto 29, 2024
PRESS RELEASE

Idaho Doctor Pays $96,000 to Settle Allegations That He Wrote Unlawful Prescriptions

Abril 03, 2024
POCATELLO – Dr. Gerald Knouf, a family medicine doctor formerly of Pocatello, Idaho, agreed to pay $96,000 to resolve allegations that he wrote unlawful prescriptions, prescribed dangerous combinations of drugs, and billed Medicare and Medicaid for services that were not performed, U.S. Attorney Josh Hurwit announced today. The settlement also...
Abril 03, 2024
PRESS RELEASE

DEA Announces Settlement with Morris & Dickson Co., LLC

Febrero 07, 2024
WASHINGTON, D.C. – The U.S. Drug Enforcement Administration announced today a settlement with pharmaceutical distributor Morris & Dickson Co., LLC for failing to maintain effective controls against diversion of controlled substances, including failure to report to DEA thousands of unusually large orders of oxycodone and hydrocodone. Morris & Dickson, which...
Febrero 07, 2024
PRESS RELEASE

DEA Executes Operation Bottleneck to Prevent the Diversion of Controlled Substances and Keep Communities Safe

Octubre 31, 2023
WASHINGTON – Today, the U.S. Drug Enforcement Administration announced administrative actions against six DEA-registered companies which, together, failed to account for more than a million doses of opioids. Under DEA initiative “Operation Bottleneck,” DEA served an Immediate Suspension Order and five Orders to Show Cause over a one-month period from...
Octubre 31, 2023
PRESS RELEASE

Ferry County Hospital District Agrees to Pay $15,000 Penalty and Implement Corrective Actions to Address Improper Opioid Dispensing Practices at Republic Pharmacy

Octubre 02, 2023
SPOKANE, Wash.– The Ferry County Hospital District agreed to pay a $15,000 Controlled Substances Act penalty and to institute corrective actions in regards to opioid prescribing practices at Republic Drug Store, a pharmacy in Republic, Washington, that Ferry County Hospital District purchased in January 2021 and has continued to operate...
Octubre 02, 2023
PRESS RELEASE

Former Alaska Advanced Nurse Practitioner Sentenced to 30 Years for Illegally Prescribing Millions of Opioids Causing Five Deaths

Junio 16, 2023
ANCHORAGE, ALASKA—Former Advanced Nurse Practitioner Jessica Joyce Spayd (52) was sentenced in U.S. District Court yesterday to 30 years (360 months) imprisonment for illegally prescribing and dispensing opioids outside the scope of legitimate medical practice that resulted in the deaths of five people between 2014 and 2019. United States District...
Junio 16, 2023
PRESS RELEASE

DEA, SAMHSA Extend COVID-19 Telemedicine Flexibilities for Prescribing Controlled Medications for Six Months While Considering Comments from the Public

Mayo 09, 2023
WASHINGTON – Today, ahead of the expiration of the COVID-19 Public Health Emergency (PHE), the Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) issued the “Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications” – a temporary rule that extends telemedicine flexibilities...
Mayo 09, 2023
PRESS RELEASE

DEA Announces Proposed Rules for Permanent Telemedicine Flexibilities

Febrero 24, 2023
WASHINGTON - Today, the Drug Enforcement Administration announced proposed permanent rules for the prescribing of controlled medications via telemedicine, expanding patient access to critical therapies beyond the scheduled end of the COVID-19 public health emergency. The public will be able to comment for 30 days on the proposed rules. The...
Febrero 24, 2023
Showing 1 - 10 of 16 results

Paginación

  • Current page 1
  • Página 2
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster